Xenon Pharmaceuticals Inc (STU:XP0)
€ 38.4 -0.2 (-0.52%) Market Cap: 2.90 Bil Enterprise Value: 2.27 Bil PE Ratio: 0 PB Ratio: 3.56 GF Score: 47/100

Xenon Pharmaceuticals Inc XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs Transcript

Sep 19, 2023 / 03:30PM GMT
Release Date Price: €34
Operator

Good morning, and welcome to the Xenon Pharmaceuticals Investor Webinar. Please note, this webcast is being recorded and broadcasted live on the Investors section of Xenon's website. This broadcast is property has been on pharmaceuticals and recording, reproduction or transmission of this call without the expressed written consent of Xenon is strictly prohibited. (Operator Instructions) I would now like to introduce Ian Mortimer, President and CEO of Xenon Pharmaceuticals, who will act as a moderator of today's event. Mr. Mortimer, you may go ahead.

Ian C. Mortimer
Xenon Pharmaceuticals Inc. - President, CEO & Director

Thank you, operator, and good morning, everyone, and thanks for joining us today on our webinar. And apologies for starting a few minutes late. We just had a few technical issues that we were working through. But we will try to have the full 90 minutes because we have a full agenda today. Before we begin, I'll point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot